NEWS
Some Children with Hodgkin Lymphoma May Not Need Radiation Therapy
Children with Hodgkin lymphoma who have favorable clinical features and who respond early to chemotherapy may not need treatment with radiation. The finding, reported in the June 27 JAMA, is from a clinical trial of 88 patients with low-risk disease.
Patients who had an early complete response to the chemotherapy regimen used in the trial and were not treated with radiation therapy (as stipulated in the study protocol) had 5-year survival rates similar to those of children who did not have the same response to chemotherapy and therefore required radiation. Read more > >
Test May Reduce the Need for Surgery to Diagnose Thyroid Cancer
Approach would apply to patients for whom earlier tests were inconclusiveSkin Cancers Traced to Previously Unknown Effect of UV Radiation
Studies in mice suggest changes to stromal cells may set the stage for cancerExperimental Drug Based on Plant Toxin Targets and Kills Tumor Cells
Researchers have initiated an early-phase clinical trial of the drugAlso in the Journals: Cells Most Vulnerable to HPV Identified
COMMENTARY
Cancer Survivorship Research: Translating Science to Care
The director of NCI's Office of Cancer Survivorship shares some highlights from the Sixth Biennial Cancer Survivorship Research Conference
A MESSAGE TO READERS
Special Issue on Oncology Nursing
Don't miss our July 24 special issue, which will highlight the role of nurses in cancer care. Topics will include the role of nurse navigators, the partnership between oncologists and nurses, how nurses support family caregivers, clinical trial ethics and oncology nursing, and compassion fatigue among oncology nurses and how to address it.
Past special issues have focused on obesity and cancer research, adolescent and young adult cancers, and clinical trials enrollment.
IN DEPTH
To Eat or Not to Eat: With Cancer Therapies, That Is the Question
Researchers are testing how changing food intake may improve anticancer treatment and reduce side effects
Featured Clinical Trial: MRI-Guided Focal Laser Therapy for Low-Risk Prostate Cancer
Will prostate-sparing laser therapy be safe and effective against low-volume, low-grade disease?
A Meeting of Minds: Young Oncologists Make the Most of the ASCO Annual Meeting
Most find new opportunities while reinforcing their commitment to cancer research
UPDATES
FDA Update
- FDA Approves Test to Aid Post-PSA Biopsy Decisions
Cancer.gov Update
- Popular NCI Publications Now Available as E-Books
- NCI Mobile Website Rated among Top 10 Federal Apps
Notes
- Free Workshop for Cancer Survivors: Managing Post-Treatment Neuropathy
- Funding Available to Support Collaborations between U.S. and Chinese Scientists
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
